GS1-24F4.2: A Drug Target / Disease Biomarker (G100652791)

Target Name: GS1-24F4.2

NCBI ID: G100652791

GS1-24F4.2

Other Name(s): Uncharacterized LOC100652791 | uncharacterized LOC100652791

GS1-24F4.2: A Drug Target / Disease Biomarker

GS1-24F4.2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling.

GS1-24F4.2 is known for its role in the regulation of pain and inflammation. It is highly expressed in the brain and has been shown to play a critical role in the development and progression of pain neuropathways.

GS1-24F4.2 is also expressed in other tissues and has been shown to play a role in various physiological processes, including blood pressure, bone density, and stem cell biology.

Due to its potential role in pain and inflammation, GS1-24F4.2 has been identified as a potential drug target. Researchers are currently working to develop small molecules that can selectively modulate GS1-24F4.2 activity and treat a variety of conditions, including pain, inflammation, and neurodegenerative diseases.

In addition to its potential as a drug target, GS1-24F4.2 also has significant potential as a biomarker. Its expression is highly correlated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and inflammatory diseases.

By studying the expression and function of GS1-24F4.2, researchers may be able to identify new biomarkers for the diagnosis and treatment of these diseases. Additionally, by developing small molecules that can modulate GS1-24F4.2 activity, researchers may be able to develop new treatments for pain, inflammation, and other conditions.

Overall, GS1-24F4.2 is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in the regulation of pain and inflammation and to develop new treatments for a variety of conditions.

Protein Name: Uncharacterized LOC100652791

The "GS1-24F4.2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GS1-24F4.2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets